USFDA grants Orphan Drug Designation (ODD) to Zydus’ Desidustat for treatment of beta-thalassemia Read more
Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg Read more
Alembic Pharmaceuticals gains USFDA final approval for Carbamazepine Extended-Release Tablets Read more
FDA approves 127 innovator and biosimilar drugs in 2024, marks shift in pharma approval landscape Read more
Biocon Biologics gains USFDA approval for Kirsty, Interchangeable Rapid-Acting Insulin Aspart Read more